A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of DS-3801b, a Motilin Receptor Agonist, in Healthy Subjects.
about
A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of DS-3801b, a Motilin Receptor Agonist, in Healthy Subjects.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A Phase 1 Study to Assess the ...... Agonist, in Healthy Subjects.
@en
A Phase 1 Study to Assess the ...... Agonist, in Healthy Subjects.
@nl
type
label
A Phase 1 Study to Assess the ...... Agonist, in Healthy Subjects.
@en
A Phase 1 Study to Assess the ...... Agonist, in Healthy Subjects.
@nl
prefLabel
A Phase 1 Study to Assess the ...... Agonist, in Healthy Subjects.
@en
A Phase 1 Study to Assess the ...... Agonist, in Healthy Subjects.
@nl
P2093
P2860
P356
P1476
A Phase 1 Study to Assess the ...... Agonist, in Healthy Subjects.
@en
P2093
George Atiee
Giorgio Senaldi
Justin Dennie
Kiyoshi Morimoto
Vance Warren
P2860
P304
P356
10.1002/JCPH.919
P577
2017-05-02T00:00:00Z